Skip to main content
. 2022 Mar 3;81:100900. doi: 10.1016/j.resmer.2022.100900

Table 4.

Multivariable analyses for risk of hospitalization.

B S.E. Sig. Exp (B)
Pirfenidone use 0.06 0.87 0.93 1.07
Comorbidity 20.93 28,410.67 0.99 1.08
LTOT 0.87 1.13 0.43 2.40
BMI, kg/m2 −0.05 0.09 0.59 0.94
FVC,% −0.00 0.02 0.87 0.99
DLCO,% −0.00 0.03 0.88 0.99

BMI: Body mass index; LTOT: long term oxygen treatment.